Charles Stacey brings over 20 years of healthcare experience spanning clinical practice, entrepreneurship, and investment. He served as President and CEO of Cerecin, a biotechnology company focused on neurology drug development.

His venture capital experience includes work with Inventages, a Nestle-affiliated global healthcare fund with $1.5 billion in assets under management, where he supported interests in neuroscience and digital health. Prior to Inventages, Dr. Stacey worked in venture capital in the USA, and as a co-founder, he ran an orthopedics medical device company that spun out of his surgical practice, giving him firsthand understanding of the challenges of building MedTech businesses from the ground up.

Dr. Stacey originally trained and practiced as a trauma and reconstructive surgeon at King’s College London and is a member of the Royal College of Surgeons and the General Medical Council, UK. This clinical background provides valuable perspective on the real-world application of medical technologies. This combination of clinical, operational, and investment expertise enables him to assess both the technical merit and commercial viability of emerging MedTech innovations.